Richard Mohs

Chief Scientific Officer at The Gap Foundation

Richard Mohs

Richard Mohs

Chief Scientific Officer at The Gap Foundation

Overview
RelSci Relationships

2246

Number of Boards

2

Relationships
RelSci Relationships are individuals Richard Mohs likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founding Executive Director & Chief Science Officer at Alzheimer's Drug Discovery Foundation

Relationship likelihood: Strong

Co-Founder at Alzheimer's Drug Discovery Foundation

Relationship likelihood: Strong

Founder at Ronald S. Lauder Foundation

Relationship likelihood: Strong

Director, Client Service & Marketing at Bridgewater Associates LP

Relationship likelihood: Strong

Executive Director & Chief Operating Officer at Alzheimer's Drug Discovery Foundation

Relationship likelihood: Strong

Chief Executive Officer, Executive Director & MD at CogState Ltd.

Relationship likelihood: Strong

Former Venture Partner at Third Rock Ventures LLC

Relationship likelihood: Strong

Assistant Secretary & Treasurer at Alzheimer's Drug Discovery Foundation

Relationship likelihood: Strong

Agent at Corcoran Group Real Estate

Relationship likelihood: Strong

Founder at Nancy Corzine Inc.

Relationship likelihood: Strong

Paths to Richard Mohs
Potential Connections via
Relationship Science
You
Richard Mohs
Chief Scientific Officer at The Gap Foundation
Education

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

Career History
Vice President, Clinical Development
2015 - Prior

AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer's. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD.

Chief Scientific Officer
Current
Vice President-Neuroscience Early Clinical Development
2002 - 2015

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Boards & Committees
Independent Non-Executive Director
2017 - Current

Cogstate Ltd. is a global cognitive science company. It delivers software services to optimize the measurement of cognition in clinical trials, academic research, healthcare and brain injury. The company operates through the following segments: Clinical Trials, Precision Recruitment, Healthcare and Sport. The Clinical Trials segment includes products and services were sold to pharmaceutical and biotechnology companies to quantify the effect of drugs or other interventions on humans. The Precision Recruitment segment includes technology is used to recruit patients for clinical drug trials. The Healthcare segment includes technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. The Sports segment includes technology and associated services are used to provide concussion management tools in sport as well as skill training for athletes. Cogstate was founded by David Gordon Darby and Paul Maruff on December 17, 1999 and is headquartered in Melbourne, Australia.

Member-Governors Board
Current

The Alzheimer’s Drug Discovery Foundation was established in 2004 as a public charity to support the advancement of drugs to prevent, treat, and cure Alzheimer’s disease, related dementias, and cognitive aging. This strategy of venture philanthropy is based on the idea that research grant recipients are engaged in projects that are potentially viable in the marketplace with a possible return on investment.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Richard Mohs. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Richard Mohs's profile does not indicate a business or promotional relationship of any kind between RelSci and Richard Mohs.